Impulsivity has been variously defined as behavior without adequate thought, the tendency to act with less forethought than do most individuals of equal ability and knowledge, or a predisposition toward rapid, unplanned reactions to internal or external stimuli without regard to the negative consequences of these reactions.
Impulsivity is implicated in a number of psychiatric disorders including Mania, Personality Disorders, and Substance Use Disorders; yet, there is significant disagreement among researchers and clinicians regarding the exact definition of impulsivity and how it should be measured.
The Clinical Trials Network Western States Node presented the webinar “Neuroscience of Impulsivity & Addictive Disorders,” in collaboration with the Central Rockies, Northwest, and Pacific Southwest ATTCs. Suzanne Mitchell, Ph.D., of the Methamphetamine Abuse Research Center at Oregon Health and Science University, discussed measures of impulsivity and how performance on these measures can predict changes in addictive behaviors. She also discussed factors that impact impulsivity, from genetics to adversity and stress, and substance withdrawal symptoms.
This free webinar offers 1.5 free NAADAC CEUs.
The Central Rockies ATTC is managed by the Utah Addiction Center at the University of Utah Health Sciences Center. Through a collaborative partnership with the University of Nevada, Reno, and the University of Iowa, the Central Rockies ATTC facilitates workforce development for treatment professionals providing training and technical assistance on evidence-based practices, the National Institute on Drug Abuse (NIDA) Blending Products and the Substance Abuse and Mental Health Services Administration (SAMHSA) Initiatives.
Want to hear more and get updates about trainings and products available in your state?